Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis

Rheumatology International

Volumn 32, Issue 1, 2012, Pages 273-275

  Orden, Alberto O ^a   Chuluyan, Juan C ^a   Colombini, Ana C ^a   Barbera, Rubén F ^a  

^a Clínica San Camilo ^*  (Argentina)

Author keywords

Cytomegalovirus; Dermatomyositis; Leflunomide

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEFLUNOMIDE; MEPREDNISONE; METHOTREXATE;

ADULT; ANTIVIRAL ACTIVITY; ARTICLE; ASTHENIA; CASE REPORT; CYTOMEGALOVIRUS INFECTION; DERMATOMYOSITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMAN; MYALGIA; PRIORITY JOURNAL;

ANTIRHEUMATIC AGENTS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DERMATOMYOSITIS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; METHOTREXATE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; TREATMENT OUTCOME;

EID: 84857124141     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-010-1786-6     Document Type: Article

References (15)

1. A Hashimoto R Okuyama H Watanabe H Tagami S Aiba 2006 Cytomegalovirus infection complicating immunosuppressive therapy for dermatomyositis Acta Derm Venereol 86 6 535 537 17106602 (Pubitemid 44950748)
2. Y Takizawa S Inokuma Y Tanaka K Saito T Atsumi M Hirakata H Kameda S Hirohata H Kondo S Kumagai Y Tanaka 2008 Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population Rheumatology (Oxford) 47 9 1373 1378 1:STN:280: DC%2BD1crjtVOmtg%3D%3D
3. C Steininger 2007 Novel therapies for cytomegalovirus disease Recent Patents Anti-Infect Drug Disc 2 1 53 72 1:CAS:528:DC%2BD2sXhsVWit7k%3D (Pubitemid 46729087)
4. WJ Waldman DA Knight L Blinder J Shen NS Lurain DM Miller DD Sedmak JW Williams AS Chong 1999 Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide Intervirology 42 5-6 412 418 10702725 1:CAS:528:DC%2BD3cXisVKisLk%3D (Pubitemid 30122078)
5. AS Chong H Zeng DA Knight J Shen GT Meister JW Williams WJ Waldman 2006 Concurrent antiviral and immunosuppressive activities of leflunomide in vivo Am J Transplant 6 1 69 75 16433758 1:CAS:528:DC%2BD28Xpt1GqtQ%3D%3D (Pubitemid 43382202)
6. GT John J Manivannan S Chandy S Peter DH Fleming SJ Chandy N Balakrishnan K Krishnamurthy MG Kirubakaran CK Jacob 2005 A prospective evaluation of leflunomide therapy for cytomegalovirus disease in renal transplant recipients Transplant Proc 37 10 4303 4305 16387103 1:CAS:528:DC%2BD28XktlCr (Pubitemid 43016014)
7. N Leca 2009 Leflunomide use in renal transplantation Curr Opin Organ Transplant 14 4 370 374 19512928
8. VS Sangle SR Sangle DP D'Cruz 2008 Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis Ann Rheum Dis 67 5 723 18408111 1:STN:280:DC%2BD1c3kslyrtg%3D%3D (Pubitemid 351571942)
9. DL Evers X Wang SM Huong KA Andreoni ES Huang 2005 Inhibition of human cytomegalovirus signaling, replication by the immunosuppressant FK778 Antiviral Res 65 1 1 12 15652966 1:CAS:528:DC%2BD2MXkvFenug%3D%3D (Pubitemid 40094769)
10. RK Avery 2008 Update in management of ganciclovir-resistant cytomegalovirus infection Curr Opin Infect Dis 21 4 433 437 18594298
11. CE Araya EH Garin RE Neiberger VR Dharnidharka 2010 Leflunomide therapy for BK virus allograft nephropathy in pediatric, young adult kidney transplant recipients Pediatr Transplant 14 1 145 150 19344337
12. S Teschner P Gerke M Geyer J Wilpert B Krumme T Benzing G Walz 2009 Leflunomide therapy for polyomavirus-induced allograft nephropathy: efficient BK virus elimination without increased risk of rejection Transplant Proc 41 6 2533 2538 19715969 1:CAS:528:DC%2BD1MXhtVKmu77N
13. K Ehlert AH Groll J Kuehn J Vormoor 2006 Treatment of refractory CMV-infection following hematopoietic stem cell transplantation with the combination of foscarnet, leflunomide Klin Padiatr 218 3 180 184 16688677 1:STN:280:DC%2BD283mtlCkug%3D%3D (Pubitemid 43805941)
14. M Battiwalla P Paplham NG Almyroudis A McCarthy A Abdelhalim A Elefante P Smith J Becker PL McCarthy BH Segal 2007 Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation Transpl Infect Dis 9 1 28 32 17313468 1:STN:280:DC%2BD2s7hvVartw%3D%3D
15. John GT, Manivannan J, Chandy S, Peter S, Jacob CK (2004) Leflunomide therapy for cytomegalovirus disease in renal allograft recepients. Transplantation. 15; 77(9):1460-1 (Pubitemid 38668445)